These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 18375481)
1. Laboratory assessment of HDL heterogeneity and function. Movva R; Rader DJ Clin Chem; 2008 May; 54(5):788-800. PubMed ID: 18375481 [TBL] [Abstract][Full Text] [Related]
2. [Laboratory assessment of HDL heterogeneity and function]. Movva R; Rader DJ Ann Biol Clin (Paris); 2009; 67(1):7-21. PubMed ID: 19189882 [TBL] [Abstract][Full Text] [Related]
3. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation. Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ Circ Res; 2005 Oct; 97(8):763-71. PubMed ID: 16151025 [TBL] [Abstract][Full Text] [Related]
4. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity. Sparks DL; Frank PG; Neville TA Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105 [TBL] [Abstract][Full Text] [Related]
5. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles. Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251 [TBL] [Abstract][Full Text] [Related]
6. Trimerized apolipoprotein A-I (TripA) forms lipoproteins, activates lecithin: cholesterol acyltransferase, elicits lipid efflux, and is transported through aortic endothelial cells. Ohnsorg PM; Mary JL; Rohrer L; Pech M; Fingerle J; von Eckardstein A Biochim Biophys Acta; 2011 Dec; 1811(12):1115-23. PubMed ID: 21930241 [TBL] [Abstract][Full Text] [Related]
8. Structure and function of apolipoprotein A-I and high-density lipoprotein. Segrest JP; Li L; Anantharamaiah GM; Harvey SC; Liadaki KN; Zannis V Curr Opin Lipidol; 2000 Apr; 11(2):105-15. PubMed ID: 10787171 [TBL] [Abstract][Full Text] [Related]
9. Detailed molecular model of apolipoprotein A-I on the surface of high-density lipoproteins and its functional implications. Segrest JP; Harvey SC; Zannis V Trends Cardiovasc Med; 2000 Aug; 10(6):246-52. PubMed ID: 11282302 [TBL] [Abstract][Full Text] [Related]
10. [High-density lipoprotein (HDL) and cholesteryl ester transfer protein (CETP): role in lipid metabolism and clinical meaning]. Kleber ME; Grammer TB; März W MMW Fortschr Med; 2010 Jul; 152 Suppl 2():47-55. PubMed ID: 21591319 [TBL] [Abstract][Full Text] [Related]
11. Influence of serum amyloid A on cholesterol esterification in human plasma. Steinmetz A; Hocke G; Saïle R; Puchois P; Fruchart JC Biochim Biophys Acta; 1989 Nov; 1006(2):173-8. PubMed ID: 2512983 [TBL] [Abstract][Full Text] [Related]
12. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT. Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726 [TBL] [Abstract][Full Text] [Related]
13. Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux. Czarnecka H; Yokoyama S Biochemistry; 1995 Apr; 34(13):4385-92. PubMed ID: 7703252 [TBL] [Abstract][Full Text] [Related]
14. Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes. Fournier N; Atger V; Paul JP; de la Llera Moya M; Rothblat G; Moatti N Atherosclerosis; 1999 Dec; 147(2):227-35. PubMed ID: 10559507 [TBL] [Abstract][Full Text] [Related]
15. [Advances in apolipoprotein A- I and it's anti-atherosclerosis properties]. Li M; Liu ZM Sheng Wu Gong Cheng Xue Bao; 2003 Jul; 19(4):387-91. PubMed ID: 15969051 [TBL] [Abstract][Full Text] [Related]
16. The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase. Nobecourt E; Davies MJ; Brown BE; Curtiss LK; Bonnet DJ; Charlton F; Januszewski AS; Jenkins AJ; Barter PJ; Rye KA Diabetologia; 2007 Mar; 50(3):643-53. PubMed ID: 17216278 [TBL] [Abstract][Full Text] [Related]
18. Elevated high density lipoprotein concentrations in heart transplant recipients are related to impaired plasma cholesteryl ester transfer and hepatic lipase activity. Atger V; Leclerc T; Cambillau M; Guillemain R; Marti C; Moatti N; Girard A Atherosclerosis; 1993 Oct; 103(1):29-41. PubMed ID: 8280183 [TBL] [Abstract][Full Text] [Related]
19. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins. Frank PG; N'Guyen D; Franklin V; Neville T; Desforges M; Rassart E; Sparks DL; Marcel YL Biochemistry; 1998 Sep; 37(39):13902-9. PubMed ID: 9753480 [TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase. Nakamura Y; Kotite L; Gan Y; Spencer TA; Fielding CJ; Fielding PE Biochemistry; 2004 Nov; 43(46):14811-20. PubMed ID: 15544352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]